TAKEDA PHARMACEUTICAL COMPANY LIMITED

The safety and efficacy of the compounds under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available for the uses being investigated. The clinical trial information is available at www.clinicaltrials.gov. with the exception of the Hemophilia Point of Care Diagnostic Device... This interactive pipeline is initiated, organized and funded by Takeda. ©2021 Takeda Pharmaceutical Company Limited, Lexington, MA 02421. TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited All rights reserved. VV-MEDMAT-6582 June 2021... ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)††